EcoDrugPlus

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSOMEG00000002410
Gene Symbol: GUCY1A2
4 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSOMEG00000009617
Gene Symbol: GUCY1B1
3 Cross references
210 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class B Member 1

Ensembl ID : ENSOMEG00000023196
Gene Symbol: HSP90AB1
1 Cross references
339 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha 1

Ensembl ID : ENSOMEG00000004944
Gene Symbol: LOC112137228
3 Cross references
345 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSOMEG00000011585
Gene Symbol: HMGB1
2 Cross references
511 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSOMEG00000002610
Gene Symbol: LOC112149362
3 Cross references
509 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSOMEG00000000546
Gene Symbol: HRH1
2 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSOMEG00000006985
Gene Symbol: HRH2
3 Cross references
182 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSOMEG00000021942
Gene Symbol: HRH2A
1 Cross references
189 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSOMEG00000014289
Gene Symbol: LOC112148948
4 Cross references
255 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSOMEG00000014338
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSOMEG00000023880
Gene Symbol: HDAC11
3 Cross references
101 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).